COMPARISON OF LIPID PROFILE IN DIABETIC AND NON DIABETIC MALE AND FEMALE BELOW AND ABOVE THE 45 YEARS OF AGE GROUP

Similar documents
JMSCR Vol 06 Issue 09 Page September 2018

YOUR INFORMATION. Ischemic Heart Disease

Normal cholesterol level for men over 50

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus

Frequency of Dyslipidemia and IHD in IGT Patients

What is Diabetes Mellitus?

INTERNATIONAL LIPOPROTEIN STANDARDIZATION FORUM Fasting Time and Lipid Levels in a Community-Based Population: A Crosssectional

Status of LDL Oxidation and antioxidant potential of LDL in Type II Diabetes Mellitus

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

Impact of Chronicity on Lipid Profile of Type 2 Diabetics

Ezetimib Stada 10 mg tablets

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Current Cholesterol Guidelines and Treatment of Residual Risk COPYRIGHT. J. Peter Oettgen, MD

International Journal of Basic and Applied Physiology

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

Effect of mixed diet on lipid fractions levels in Coronary Heart diseases in adults of western Maharashtra region of India.

Diabetes and the Heart

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Evaluation of Serum Magnesium Level along with Lipid Profile in a Gujarati Population diagnosed with Diabetes Mellitus

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Rick Fox M.A Health and Wellness Specialist

Also, some risk factors, such as smoking and diabetes, put you at greater risk for CHD and heart attack than others.

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

JMSCR Vol 05 Issue 05 Page May 2017

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015

1. Most of your blood cholesterol is produced by: a. your kidneys b. your liver c. your pancreas d. food consumption (Your liver)

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Comparison of Glucose & Lipid Profiles in Oxidative Stress Contain Diabetic Patients

Spotty Calcification as a Marker of Accelerated Progression of Coronary Atherosclerosis : Insights from Serial Intravascular Ultrasound

A Study on Prevalence of Co-Morbidities among Hypothyroidism Patients in Various Hospitals- Palakkad.

Pattern of plasma lipoprotein (a) in Sudanese patients with coronary

Cardiovascular Disease Risk Factors:

Inspired Functional Ingredients to Innovate and Differentiate Your Brand. Products by Ecovatec Solutions Inc.

The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences

LIPID GUIDELINES: 2015

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

The American Diabetes Association estimates

Arteriosclerosis & Atherosclerosis

Dyslipidemia in women: Who should be treated and how?

Conceptual Approach to CAD Risk. Disclosures. Integrating Imaging and Biomarkers for Optimal CVD Risk Assessment and Management 2/10/2014.

Selected Overweight- and Obesity- Related Health Disorders

The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India

The Best Lipid Fraction for the Prediction of the Population at Risk of Atherothrombotic Disease. William E. Feeman, Jr., M.D.

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

EFFECT OF LYCOPENE IN TOMATO SOUP AND TOMATO JUICE ON THE LIPID PROFILE OF HYPERLIPIDEMIC SUBJECTS

Medical - Clinical Research & Reviews

Protecting the heart and kidney: implications from the SHARP trial

Cardiovascular Complications of Diabetes

Know Your Numbers. The Life Saving Numbers You Need To Know

Association of hypothyroidism with metabolic syndrome - A case- control study

Statistical Fact Sheet Populations

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

A loss-of-function variant in CETP and risk of CVD in Chinese adults

Counseling and Long-term Follow up After Gestational Disorders

Wellness: Concepts and Applications 8 th Edition Anspaugh, Hamrick, Rosato

Feeding Effect of Terminalia Arjuna and Guggul on the Biophysical Symptoms of Dyslipidemic Patients Jain Bharti 1,Pathak Sakshi 2 and Yadav Shubha 3

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

CVD risk assessment using risk scores in primary and secondary prevention

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital

N. Rajya Lakshmi et al : Early Clinical Exposure. Abdominal circumference its relation to blood lipid levels in new born.

Welcome and Introduction

ISCHEMIC HEART DISEASE: Role of Total Cholesterol: HDL C Ratio as an Important Indicator Compared to LDL C.

CLINICAL OUTCOME Vs SURROGATE MARKER

Your Guide to Managing and Understanding Your Cholesterol Levels

JMSCR Vol 06 Issue 12 Page December 2018

How would you manage Ms. Gold

Normal cholesterol levels for men over 50

STUDY OF SERUM CHOLESTEROL BINDING RESERVE AND CHOLESTEROL LEVELS IN MYOCARDIAL INFARCTION PATIENTS AT TERTIARY CARE HOSPITAL FROM CENTRAL INDIA

To the Editor, I was delighted to read the lead article (in the Autumn issue of The Lipid Spin) by Maria Luz Fernandez, PhD, concerning the use of

What should I eat? I am so confused. Jennifer Lyon DO

Normal blood vessels A= artery V= vein

Permission Granted!! Women Take Care of Your Hearts! October 22, 2016

Familial hypercholesterolaemia in children and adolescents

Phytosterol/stanol enriched foods

Imaging-Guided Statin Allocation: Seeing Is Believing

Therapeutic effect of flavonoid rich extract of apricots on high-fat diet induced hyperlipidemia in rabbits

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

The JUPITER trial: What does it tell us? Alice Y.Y. Cheng, MD, FRCPC January 24, 2009

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

CONTRIBUTING FACTORS FOR STROKE:

03/30/2016 DISCLOSURES TO OPERATE OR NOT THAT IS THE QUESTION CAROTID INTERVENTION IS INDICATED FOR ASYMPTOMATIC CAROTID OCCLUSIVE DISEASE

CARING FOR A LOVED ONE AFTER A HEART ATTACK OR STROKE

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

Correlation between triglyceride level and carotid intima media thickness in patients with type 2 diabetes mellitus

Cardiovascular Disease

Diabetic Dyslipidemia

Current evidence on the effect of DPP-4 inhibitor drugs on mortality in type 2 diabetic (T2D) patients: A meta-analysis

IMPACT OF APPLE CIDER VINEGAR ON DIFFERENT BIOMARKERS, FOR REDUCING TYPE 2 DIABETES MELLITUS CONDITION

Dr.Kamal Waheeb AlGhalayini MD, SCC Med. MSc-Card Associate professor, Consultant Cardiology. Head non-invasive lab. Vice dean for clinical affaires

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery

Dr Anne King dc life dclife.co.uk

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Natural Approaches to Cholesterol Deregulation

Prevention of Cardiovasular Diseases

Lipoprotein (a), C-Reactive protein and serum uric acid as cardiovascular risk factors in type 2 diabetes mellitus

Transcription:

8 COMPARISON OF LIPID PROFILE IN DIABETIC AND NON DIABETIC MALE AND FEMALE BELOW AND ABOVE THE 45 YEARS OF AGE GROUP *DR OMNATH PRASAD YADAV, **DR HITESHKUMAR K SOLANKI, ***DR KRISHNA SINGH, ****DR N P GOPINATH, C. U. S. M. C., Surendranagar *Associate Professor of Physiology (Author) **Assistant Professor of Physiology ***Professor of Physiology (Darbhanga Medical College. Bihar) ****Professor of Physiology ABSTRACT INTRODUCTION: Incidence of diabetes mellitus in human population has reached epidemic proportions worldwide, and it is increasing at rapid rate.many large scale analyses have demonstrated a nearly linear correlation between the total cholesterol and low density lipoprotein (LDL) cholesteroland the severity of atherosclerosis. It has also been seen the inverse relationship between symptomatic atherosclerosis and the high density lipoprotein (HDL) cholesterol level. OBJECTIVE: The goal of our study is to estimate blood sugar, total cholesterol, HDL and LDL level in male and female.method: 40 male and 40 female are below the 45 years of age and 40 male and 40 female are above the 45 years of age. In the present study 80 normal individuals (Controls) and 80 diabetic patients suffering from Non-insulin dependent diabetics mellitus have been investigated. The entire subject were instructed about study and written consent taken. History and clinical examination was done.blood sugar, total serum cholesterol, serum and serum HDL cholesterol level is estimated in biochemistry laboratory by calorimetric method. Statistical analysis was done by unpaired t test. P value less than 0.05 considered as a significant. RESULTS: level is not significantly (p > 0.05) change in diabetic and non diabetic. HDL cholesterol level is significantly (p < 0.001) lower in diabetic patients as compared to non diabetics. is not significantly (p > 0.05) change in diabetic and non diabetic. level and level are significantly (p < 0.001) higher in above 45 years male and female than below 45

years of male and female. HDL cholesterol level is significantly (p < 0.001) higher in above 45 years of female than below 45 years of female but HDL cholesterol level is not significantly (p > 0.05) change in below and above 45 years of male. CONCLUSION: level is not significantly (p > 0.05) change in diabetic and non diabetic. HDL cholesterol level is significantly (p < 0.001) lower in diabetic patients as compared to non diabetics. is not significantly (p > 0.05) change in diabetic and non diabetic. KEY WORDS: Diabetes mellitus Atheroscelrosis HDL HDL Myocardial ischaemia INTRODUCTION: Diabetes mellitus is a clinical syndrome characterized by chronic hyperglycemia and disturbance of carbohydrate, fat and protein metabolism due to absolute or relative deficiency of insulin action, evolving from interaction of varieties of genetic and environmental factors. Leurine gave the first suggestion diabetes are extremely prone to ischaemic heart disease as early as 1922 (5,6). Type 2 diabetes mellitus typically double the ischaemic heart disease in men and triples in women (1,3). In 1951, Barr et al has documented the negative association between high density lipoprotein (HDL) and ischemic heart disease. Medical expert think that HDL tends to carry cholesterol away from the arteries and back to the liver, where it s passed from the body. Some expert believed that HDL removes excess cholesterol from plaque in arteries, thus slowing the buildup (2, 5). The risk of coronary heart disease rises as blood cholesterol level increase. A person at level 240 mg/dl of total cholesterol and above have more than twice the risk of heart disease as someone whose cholesterol level is below 200 mg/dl (3). If patient do not have coronary heart disease or diabetes LDL goal is <160 mg/dl (4).If there is no coronary heart disease or diabetes and have two or more risk factors LDL goal is less than 130 mg/dl (1, 8).If coronary heart disease or diabetes are present LDL goal is < 100 mg/dl.ncep (National Cholesterol Education Programme)Guideline = HDL < 40 mg/dl as low, implying as increasedrisk of CVD.

MATERIALS AND METHODS: In the present study 80 normal individuals (Controls) and 80 diabetic patients suffering from Non-insulin dependent diabetics mellitus have been investigated. 40 male and 40 female are below the 45 years of age and 40 male and 40 female above the 45 years of age. Experimental protocol was explained and consent was taken. History was taken and clinical examination (general and systemic) done for inclusion and exclusion criteria. Inclusion criteria: 1) Male and female with age group of below and above the 45 years. 2) Healthy individual without any known disease. 3) No history of drug, blood transfusion or any condition that affect blood cell count. Exclusion criteria : 1) Individual with any known general or systemic disease. 2) Any history of drug or medication that affect blood cell count. 3) Female with pregnancy and menstrual period. 4) Any un co-operative individual. Experimental protocol : 1) All the subjects filled the consent form that they are willing to participate in the study. 2) History and clinical examination was done for inclusion and exclusion criteria. 3) Subject s blood sugar, total serum cholesterol, serum and serum HDL cholesterol level is estimated in biochemistry laboratory by calorimetric method. 4) Then mean value and standard deviation was estimated by statistical method. STATISTICAL ANALYSIS:

Unpaired t test is used for analysis and P value less than 0.05 consider as a significant. RESULTS: level is not significantly (p > 0.05) change in diabetic and non diabetic. HDL cholesterol level is significantly (p < 0.001) lower in diabetic patients as compared to non diabetics. is not significantly (p >0.05) change in diabetic and non diabetic. level and LDL cholesterol level are significantly (p < 0.001) higher in above 45 years male and female than below 45 years of male and female. HDL cholesterol level is significantly (p < 0.001) higher in above 45 years of female than below 45 years of female but HDL cholesterol level is not significantly (p > 0.05) change in below and above 45 years of male. TABLE 1:, HDL cholesterol, in diabetic and controls below 45 years of age of male. HDL cholesterol 184.40 ± 10.59 191.05 ± 14.15 NS 46.75 ± 3.90 41.50 ± 5.03 S 124.46 ± 15.53 125.15 ± 19.80 NS TABLE 2:, HDL cholesterol, in diabetic and controls below 45 years of age of female. 163.00 ± 7.99 173.90 ± 8.20 S

HDL cholesterol 54.05 ± 2.16 50.00 ± 2.26 S 97.05 ± 7.02 98.50 ± 5.55 NS TABLE 3:, HDL cholesterol, in diabetic and controls above 45 years of age of male. HDL cholesterol 223.15 ± 27.15 225.00 ± 17.66 NS 46.90 ± 3.94 41.10 ± 1.67 S 152.25 ± 19.85 152.10 ± 18.19 NS TABLE 4:, HDL cholesterol, in diabetic and controls above 45 years of age of female. HDL cholesterol 211.20 ± 27.43 221.05 ± 12.46 NS 57.10 ± 2.21 52.00 ± 1.90 S 128.20 ± 22.07 134.60 ± 7.34 NS Data presented are Mean + SD (standard deviation)

NS: not significant (P>0.05) S: significant (P <0.05) DISCUSSION: In our study, both men and women, of age above 45 years, serum total cholesterol was found to be higher than in those below 45 years of age. In our study, the women below age group of 45 years were having significantly (p<0.001) lower serum total cholesterol level than men of same groups.havel et al (1982) also had observed a sharp rise in the level of serum total cholesterol in women after the 5 th decade of life (5).In diabetics patients, the mean total serum cholesterol concentration in men and women both are within normal limits. This observation is in accordance with those of Nikkils et al (1978), Eckel et al (1981), Harano Y et al (1996) also observed no high level of cholesterol in controlled diabetics. In control male, HDL cholesterol level is the same in both age groups under study. But, in female, there was significant (p <0.001) increase in its serum level. A gonadotropin effect on HDL may be responsible for maintenance of HDL. HDL cholesterol level between diabetic persons are not altered in men and women of ages below and above 45 years. But it is lower in comparison to the respective age group of control and this is significant. In our study in both sexes increased with ages. Male have higher level than female in both the age groups. The level of LDL cholesterol in diabetic was significantly same as in the normal in both sexes. Asayama K. et al also observed unaltered non-hdl cholesterol levels in diabetic patients. HDL cholesterol is known to have a protective role in formation of atherosclerosis also known as Cardio protective cholesterol (6,8). What is more disturbing is that in India, coronary artery disease occurs at a younger age group and the atheroma is more extensive. CONCLUSION: level is not significantly (p > 0.05) change in diabetic and non diabetic. HDL cholesterol level is significantly (p < 0.001) lower in diabetic patients as compared to non diabetics. is not significantly (p > 0.05) change in diabetic and non diabetic. REFERENCES:

1) Al Muhtaseb N.L., L. Juosuf A.RBajaj J.S.: Acta. Diabetol. Lat. 1991 Jan-Mar. 28(1), 61 9. 2) Asayama K., Miyao A, Dobashi K., Amemiya S, Ishihara T, Kato K., Attia N. et al : Diabete. Med. 1997 Mar: 14(3), 242 7. 3) Curr and Atheroscular Rep. 2000 Nov; 2(6): 476 81, Medstabl Research Institute, 108 Loving Streat, NW Anex 5, Washington DC 2001 USA. 4) Haffuer S.M.; Mykkanen L., Stren M.P. et al: Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subject. Diabetes 1993; 42: 1297 1302. 5) Kannel W.B: Lipids diabetes and coronary heart disease: heights from the Framingham study. Am. Heart. J. 1985, 110 1100 1107 (Ret. NND 499, p. 49). 6) Miller G.J. and Miller N.E: Plasma HDL concentration and development of IHD. Lancet, 1; 16, 1975. 7) Tertov V.V., Sobenim I.A., Gabbasov Z.A., Popo V.E.G, Yaroslavov A.A: Eur. J. Clin. Chem. Clin. Biochem. 1992 Apr., 30 (4): 171 8. 8) Verges B., Brun J.M., Valliant G. et al: Diab. Metab. 1992 Jul-Aug., 18(9): 289-97.